Elephas Biosciences raises $40M in Series B-2 funding to commercialize its live tumor profiling platform, with strong backing from existing investors.
Amount Raised
$40 Million
Round Type
Series B
MadisonBiotechnologyHealthcareInvestors
Description
Elephas Biosciences Corporation has announced a $40 million Series B-2 funding round. The funding will support the launch and commercialization of the Elephas Live™ Platform as a lab-developed test in 2026. Major investors include Northpond Ventures and ARCH Venture Partners. This milestone reinforces the confidence in Elephas' innovative approach to improving cancer treatment.
Quick answer
Elephas raised $40 Million in a Series B round, dated November 6, 2025. Investors: Venture Investors Health Fund, Sands Capital, Tao Capital Partners, State Of Wisconsin Investment Board, ARCH Venture Partners and Northpond Ventures. Elephas is based in Madison, Wisconsin, United States.
- How much did Elephas raise?
- Elephas raised $40 Million in a Series B round on November 6, 2025.
- Who invested in Elephas?
- Venture Investors Health Fund, Sands Capital, Tao Capital Partners, State Of Wisconsin Investment Board, ARCH Venture Partners and Northpond Ventures are named as investors in this round.
- What does Elephas do?
- Elephas is developing an ex-vivo technology suite to assess how live tumor fragments (LTFs) respond to immunotherapies.
- Where is Elephas based and how big is it?
- Elephas is based in Madison, Wisconsin, United States. Fundz records about 134 employees.
- Who are the decision-makers at Elephas?
- Fundz holds 1 contact at Elephas, including the Founder & CEO . Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Elephas that raised within 45 days of this round, from Fundz verified event records.
- Aeovian Pharmaceuticals raised $55M (Series B) on December 16, 2025.
- Lexaria Bioscience raised $3.5M on December 16, 2025.
- Jade Biosciences raised $45M (Post-IPO Equity) on December 15, 2025.
- Alphyn Biologics raised $25M (Series B) on December 12, 2025.
- Enveric Biosciences raised $107K on December 12, 2025.
- Terns Pharmaceuticals raised $196M (Post-IPO Equity) on December 11, 2025.
Who to call at Elephas, and when
A new round usually means Elephas is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Elephas raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Elephas, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Elephas. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Elephas raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansElephas raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.